CR9927A - Derivados nuevos de indolizina, su proceso de preparacion y las composiciones terapeuticas que los comprenden - Google Patents

Derivados nuevos de indolizina, su proceso de preparacion y las composiciones terapeuticas que los comprenden

Info

Publication number
CR9927A
CR9927A CR9927A CR9927A CR9927A CR 9927 A CR9927 A CR 9927A CR 9927 A CR9927 A CR 9927A CR 9927 A CR9927 A CR 9927A CR 9927 A CR9927 A CR 9927A
Authority
CR
Costa Rica
Prior art keywords
understand
preparation process
therapeutic compositions
indolizine derivatives
radical
Prior art date
Application number
CR9927A
Other languages
English (en)
Inventor
Gautier Patrick
Marchionni David
Roccon Alain
Tonnerre Bernard
Wagnon Jean
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37027751&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9927(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CR9927A publication Critical patent/CR9927A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Derivados de indolizina de formula general (I) en la que, X representa un radical -(CH2)n- siendo n un numero entero que va de 1 a 6, o un grupo de formula CH2-Z-(CH2)2-, en la que Z representa un grupo O (CH2)m- en la que m es un numero entero que va de 0 a 3, R1 representa un radical alquilo C1-C8 lineal, ramificado o ciclico; Am representa un grupo NR3R4 en el que R3 y R4 son identicos o diferentes y representan de manera independiente el uno del otro -un atomo de hidrogeno, -un radical alquilo C1-C6 lineal, ramificado o ciclico, o C1-C3 sustituido con un radical cicloalquilo C3-C6- o un radical (CH2)-O-B, en el que B representa un atomo de nitrogeno o un radical alquilo (CH2)k.
CR9927A 2005-11-23 2008-04-25 Derivados nuevos de indolizina, su proceso de preparacion y las composiciones terapeuticas que los comprenden CR9927A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0511849A FR2893616B1 (fr) 2005-11-23 2005-11-23 Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant

Publications (1)

Publication Number Publication Date
CR9927A true CR9927A (es) 2008-10-06

Family

ID=37027751

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9927A CR9927A (es) 2005-11-23 2008-04-25 Derivados nuevos de indolizina, su proceso de preparacion y las composiciones terapeuticas que los comprenden

Country Status (33)

Country Link
US (1) US7799799B2 (es)
EP (1) EP1957490B1 (es)
JP (1) JP5372514B2 (es)
KR (1) KR101419066B1 (es)
CN (1) CN101312973B (es)
AR (1) AR058208A1 (es)
AT (1) ATE454386T1 (es)
AU (1) AU2006316381B2 (es)
BR (1) BRPI0618975A2 (es)
CA (1) CA2629738C (es)
CR (1) CR9927A (es)
CY (1) CY1110623T1 (es)
DE (1) DE602006011649D1 (es)
DK (1) DK1957490T3 (es)
DO (1) DOP2006000254A (es)
EA (1) EA014158B1 (es)
EC (1) ECSP088455A (es)
ES (1) ES2338922T3 (es)
FR (1) FR2893616B1 (es)
GT (1) GT200600489A (es)
HR (1) HRP20100158T1 (es)
IL (1) IL190861A (es)
MA (1) MA30055B1 (es)
NO (1) NO20082589L (es)
PE (1) PE20071083A1 (es)
PL (1) PL1957490T3 (es)
PT (1) PT1957490E (es)
SI (1) SI1957490T1 (es)
TN (1) TNSN08162A1 (es)
TW (1) TW200738705A (es)
UY (1) UY29965A1 (es)
WO (1) WO2007060318A1 (es)
ZA (1) ZA200803565B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2893616B1 (fr) 2005-11-23 2008-01-04 Sanofi Aventis Sa Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
FR2962438B1 (fr) 2010-07-06 2012-08-17 Sanofi Aventis Derives d'indolizines, procedes de preparation et application en therapeutique
FR2962437B1 (fr) 2010-07-06 2012-08-17 Sanofi Aventis Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique
CN103360390B (zh) * 2013-07-23 2015-06-17 东南大学 中氮茚甲酰甲基对甲磺酰胺苯乙胺衍生物及其医药用途
CN110156776A (zh) * 2019-04-30 2019-08-23 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一种c-3芳甲酰基吲嗪类化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI61030C (fi) * 1976-02-19 1982-05-10 Sanofi Sa Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
US5334716A (en) * 1991-06-17 1994-08-02 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic derivatives
US6593322B1 (en) * 1999-03-17 2003-07-15 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
FR2813306B1 (fr) * 2000-08-23 2005-10-21 Sanofi Synthelabo Aminoalkybenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant
FR2893616B1 (fr) 2005-11-23 2008-01-04 Sanofi Aventis Sa Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant

Also Published As

Publication number Publication date
AU2006316381B2 (en) 2012-05-31
ES2338922T3 (es) 2010-05-13
TW200738705A (en) 2007-10-16
KR20080072000A (ko) 2008-08-05
PE20071083A1 (es) 2007-12-03
HK1126198A1 (en) 2009-08-28
WO2007060318A1 (fr) 2007-05-31
CA2629738C (fr) 2014-09-23
EA200801400A1 (ru) 2008-10-30
US20080287485A1 (en) 2008-11-20
FR2893616B1 (fr) 2008-01-04
GT200600489A (es) 2007-09-19
CN101312973B (zh) 2011-12-28
JP2009516725A (ja) 2009-04-23
IL190861A0 (en) 2008-11-03
PT1957490E (pt) 2010-03-29
CN101312973A (zh) 2008-11-26
MA30055B1 (fr) 2008-12-01
TNSN08162A1 (en) 2009-10-30
KR101419066B1 (ko) 2014-07-11
CA2629738A1 (fr) 2007-05-31
CY1110623T1 (el) 2015-04-29
ATE454386T1 (de) 2010-01-15
AR058208A1 (es) 2008-01-23
FR2893616A1 (fr) 2007-05-25
DK1957490T3 (da) 2010-05-10
IL190861A (en) 2013-02-28
JP5372514B2 (ja) 2013-12-18
AU2006316381A1 (en) 2007-05-31
ZA200803565B (en) 2009-12-30
ECSP088455A (es) 2008-06-30
US7799799B2 (en) 2010-09-21
DE602006011649D1 (de) 2010-02-25
PL1957490T3 (pl) 2010-07-30
SI1957490T1 (sl) 2010-04-30
DOP2006000254A (es) 2007-06-15
NO20082589L (no) 2008-06-10
UY29965A1 (es) 2007-06-29
EP1957490A1 (fr) 2008-08-20
HRP20100158T1 (hr) 2010-05-31
EA014158B1 (ru) 2010-10-29
EP1957490B1 (fr) 2010-01-06
BRPI0618975A2 (pt) 2011-09-20

Similar Documents

Publication Publication Date Title
AR068055A1 (es) Derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol su procedimiento de preparacion su aplicacion como medicamentos composiciones farmaceuticas y su utilizacion principalmente como inhibidores de met
AR106943A2 (es) Compuestos de isoindolina y composiciones farmacéuticas de los mismos
NO20091562L (no) 2-aryl-6-fenylimidazol{1,2-alpha}pyridin derivater, femstilling derav samt terapeutisk anvendelse derav
EP4186506A4 (en) Composition containing arylamide derivative
CO6210691A2 (es) Composicion plaguicida que comprende un compuesto sintetico util como agente de nodulacion de plantas leguiminosas y un compuestos fungicida
ES2112332T3 (es) Derivados de substitucion de oxigeno de productos de adicion de nucleofilo-oxido nitrico utilizados como promedicamentos donadores de oxido nitrico.
AR069596A1 (es) Regulador del crecimiento de plantas
BR112017000480A2 (pt) composição polimerizável, produto moldado, e uso dos mesmos
ES2723376T3 (es) Producto de limpieza
MX2025003905A (es) Tiosulfato de sodio anhidro y formulaciones de este
PE20120393A1 (es) Composiciones de asfalto mineral que contienen un organosilicio cationico
CO6320143A1 (es) Nuevos derivados dihidroindolonas su procedimeinto de preparacion y composiciones farmaceuticas que los contienen
TW201129552A (en) Salt and photoresist composition containing the same
AR097136A1 (es) Composiciones con efecto inhibidor de la ureasa mejorado que comprenden triamida del ácido (tio)fosfórico y otros compuestos
PA8768301A1 (es) Nuevos derivados tricíclicos, su procedimiento de preparación y las composiciones farmacéuticas que lo contienen
ATE422163T1 (de) Absorbierbare alpha-cyanacrylat-zusammensetzungen
NO20061872L (no) Disulfid, sulfid, sulfoksid, og sulfoderivater av sykliske sukkere og anvendelse derav
PE20070097A1 (es) Agonistas del receptor de niacina y composiciones que contienen tales compuestos
ECSP088455A (es) Nuevos derivados de indolizina, su proceso de preparación y las composiciones terapéuticas que los comprenden
AR109467A1 (es) Compuestos, procedimiento de obtención de los compuestos, composición farmacéutica, uso de los compuestos y método de tratamiento de desórdenes psiquiátricos y/o trastornos del sueño
CR9499A (es) Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
EA202190298A1 (ru) Циклические динуклеотиды в качестве агонистов sting
AR082962A1 (es) Derivados de quinoxalina y composiciones farmaceuticas
CR8735A (es) Derivados de tetrahidroisoquinolinilsulfonamidas, su preparacion y su utilizacion en terapeutica
CO5200761A1 (es) Nuevos derivados de equinocandina, su procedimiento de preparacion y su aplicacion como antifungicos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)